Legal & General Group Plc - JOUNCE THERAPEUTICS INC ownership

JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 77 filers reported holding JOUNCE THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 1.1%.

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of JOUNCE THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$6,518
+66.7%
3,5230.0%0.00%
Q4 2022$3,911
-51.1%
3,5230.0%0.00%
Q3 2022$8,000
-38.5%
3,523
-20.2%
0.00%
Q2 2022$13,000
-27.8%
4,417
+68.0%
0.00%
Q1 2022$18,000
-18.2%
2,6290.0%0.00%
Q4 2021$22,000
+10.0%
2,6290.0%0.00%
Q3 2021$20,000
+11.1%
2,6290.0%0.00%
Q2 2021$18,000
+12.5%
2,629
+73.0%
0.00%
Q1 2021$16,000
+45.5%
1,5200.0%0.00%
Q4 2020$11,000
-8.3%
1,5200.0%0.00%
Q3 2020$12,000
-20.0%
1,520
-28.5%
0.00%
Q2 2020$15,000
+50.0%
2,1260.0%0.00%
Q1 2020$10,000
-60.0%
2,126
-29.3%
0.00%
Q4 2019$25,000
+150.0%
3,0050.0%0.00%
Q3 2019$10,000
-33.3%
3,0050.0%0.00%
Q2 2019$15,000
-21.1%
3,0050.0%0.00%
Q1 2019$19,000
+171.4%
3,005
+54.8%
0.00%
Q4 2018$7,000
-46.2%
1,9410.0%0.00%
Q3 2018$13,000
-13.3%
1,9410.0%0.00%
Q2 2018$15,000
-72.2%
1,941
-19.3%
0.00%
Q1 2018$54,000
+25.6%
2,404
-28.3%
0.00%
Q4 2017$43,000
+2.4%
3,354
+23.4%
0.00%
Q3 2017$42,000
+100.0%
2,718
+75.2%
0.00%
Q2 2017$21,000
-22.2%
1,551
+26.1%
0.00%
Q1 2017$27,0001,2300.00%
Other shareholders
JOUNCE THERAPEUTICS INC shareholders Q3 2019
NameSharesValueWeighting ↓
BML Capital Management, LLC 1,087,961$2,012,7281.74%
Opaleye Management Inc. 2,880,000$5,328,0001.60%
TANG CAPITAL MANAGEMENT LLC 5,300,087$9,805,1611.46%
Ardent Capital Management, Inc. 923,463$1,708,4071.23%
Beryl Capital Management LLC 610,831$1,130,0370.89%
Arena Investors LP 610,639$1,129,6820.88%
Omega Fund Management, LLC 275,513$509,6990.33%
Deep Track Capital, LP 4,259,653$7,880,3580.32%
PenderFund Capital Management Ltd. 246,310$6160.19%
GABELLI & Co INVESTMENT ADVISERS, INC. 425,100$786,4350.15%
View complete list of JOUNCE THERAPEUTICS INC shareholders